DERMATA THERAPEUTICS -CW26 (DRMAW) Stock Technical Analysis
NASDAQ:DRMAW
Overall DRMAW gets a technical rating of 3 out of 10. Although DRMAW is scoring some points because its good overall performance in the market in the past year, recent evolutions are not that positive. Both the medium and short term picture give negative signs.
- Both the long and short term trends are negative. It is better to avoid buying stocks with negative trends.
- DRMAW is currently trading in the lower part of its 52 week range, which is not a good signal. Certainly not because the S&P500 Index is trading near new highs.
- Warning: DRMAW has an average volume of 10804 traded shares per day. This is quite low and it might be dangerous to invest in illiquid stocks.
- Looking at the yearly performance, DRMAW did better than 90% of all other stocks.
- In the last month DRMAW has a been trading in the 0.01 - 0.02 range, which is quite wide. It is currently trading in the middle of this range, so some resistance may be found above.
- Considerably lower volume is observed in the last couple of days.
Although the technical rating is bad, DRMAW does present a nice setup opportunity. We see reduced volatility while prices have been consolidating in the most recent period. There is a resistance zone just above the current price starting at 0.02. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 0.02, a Stop Loss order could be placed below this zone. We notice that large players showed an interest for DRMAW in the last couple of days, which is a good sign.
- Behavior of large players is measured by the Effective Volume indicator. This indicator inspects the 1 minute timeframe looking for high volume transactions.
More info and screens
0.01
2 important support areas can be observed.
- A support zone ranging from 0.02 to 0.02. This zone is formed by a combination of multiple trend lines and important moving averages in multiple time frames.
- Support @0.01 from a trend line in the weekly time frame.
When analyzing the resistance we notice 2 important areas.
- A resistance zone ranging from 0.02 to 0.02. This zone is formed by a combination of multiple trend lines and important moving averages in multiple time frames.
- A resistance zone ranging from 0.03 to 0.03. This zone is formed by a combination of multiple trend lines in multiple time frames.
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | DOWN | NEGATIVE | The long term trend for DRMAW is down. |
| ChartMill Short Term Trend Indicator | DOWN | NEGATIVE | The short term trend for DRMAW is down. |
| ChartMill Relative Strength | 90.86 | POSITIVE | DRMAW has a high relative strength, it outperformed 90.86% off all stocks on the market. |
| Simple Moving Average/SMA (20) | DOWN | NEGATIVE | The current price of DRMAW is below a declining SMA(20). |
| Simple Moving Average/SMA (50) | DOWN | NEGATIVE | The current price of DRMAW is below a declining SMA(50). |
| Simple Moving Average/SMA (200) | UP | MIXED | The current price of DRMAW is below the rising SMA(200). |
| Relative Strength Index/RSI (14) | 48.91 | NEUTRAL | The RSI value for DRMAW is a neutral value. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | 0 | NEGATIVE | The MACD value suggests DRMAW has a negative trend, although the MACD value is rising. |
| Stochastics (14,3) | 69.66 | NEUTRAL | The Stochastics value for DRMAW is a neutral value. |
| Average True Range in percent/ATR (20) | 22.94 | HIGH VOLATILITY | The high ATR as a percentage value for DRMAW suggests high volalility. |
| Average Directional Index/ADX (14) | 26.68 | POSITIVE | The high ADX value value for DRMAW suggests a strong trend. |
NASDAQ:DRMAW (2/12/2026, 4:00:00 PM)
0.0192
0 (-0.52%)
DERMATA THERAPEUTICS -CW26 / DRMAW FAQ
Can you provide the ChartMill technical rating for DERMATA THERAPEUTICS -CW26?
ChartMill assigns a technical rating of 3 / 10 to DRMAW.
What is the current trend direction of DERMATA THERAPEUTICS -CW26 (DRMAW) stock?
The current trend direction for DERMATA THERAPEUTICS -CW26 (DRMAW) is Bearish.
What is the RSI signal for DERMATA THERAPEUTICS -CW26 (DRMAW) stock?
DERMATA THERAPEUTICS -CW26 (DRMAW) has an RSI value of 48.9092. This indicates that the stock is currently neutral.
What is the short term momentum for DERMATA THERAPEUTICS -CW26 (DRMAW) stock?
The short term momentum for DERMATA THERAPEUTICS -CW26 (DRMAW) is negative.
What is the buy/sell signal for DRMAW stock?
The buy/sell signal for DERMATA THERAPEUTICS -CW26 (DRMAW) is sell as both the short term and long term trends are negative.